Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOdmZqUWR5MGt1TzZHMzk1SGs0dkZ3Y2R4Q0JLMWJVSENHbkM5QmlfMzliclZTcVpFWnpzLWllbG1aeUxZZXlMWUxqSF9xN0JfRWZDazhkYXlyWUNlMDdITXlzUTZyMGNZRW9zZHNFQkU5REtrZFBlRkp0V3cyMkZIQkVEbWhJck5FTS0yM044RGZkWURIVy1nSGxPQmRGakNHZTVmdVBpeHlvaHdnM0NYNi1Qal93YjU4UmdfMk9CVUtTRmQtNG5iMEVXZw?oc=5" target="_blank">Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMEli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PM